ATE279386T1 - Retinoide zur behandlung von emphysem - Google Patents
Retinoide zur behandlung von emphysemInfo
- Publication number
- ATE279386T1 ATE279386T1 AT00951439T AT00951439T ATE279386T1 AT E279386 T1 ATE279386 T1 AT E279386T1 AT 00951439 T AT00951439 T AT 00951439T AT 00951439 T AT00951439 T AT 00951439T AT E279386 T1 ATE279386 T1 AT E279386T1
- Authority
- AT
- Austria
- Prior art keywords
- retinoids
- emphysema
- treatment
- Prior art date
Links
- 206010014561 Emphysema Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/16—Unsaturated compounds
- C07C61/28—Unsaturated compounds polycyclic
- C07C61/29—Unsaturated compounds polycyclic having a carboxyl group bound to a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/66—Polycyclic acids with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99115223 | 1999-08-02 | ||
| PCT/EP2000/007091 WO2001009076A2 (en) | 1999-08-02 | 2000-07-25 | Retinoids for the treatment of emphysema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE279386T1 true ATE279386T1 (de) | 2004-10-15 |
Family
ID=8238709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00951439T ATE279386T1 (de) | 1999-08-02 | 2000-07-25 | Retinoide zur behandlung von emphysem |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US6528677B1 (de) |
| EP (1) | EP1206436B1 (de) |
| JP (1) | JP3961827B2 (de) |
| KR (1) | KR100466730B1 (de) |
| CN (1) | CN1166618C (de) |
| AR (1) | AR024998A1 (de) |
| AT (1) | ATE279386T1 (de) |
| AU (1) | AU772551B2 (de) |
| BR (1) | BR0012951A (de) |
| CA (1) | CA2386793C (de) |
| DE (1) | DE60014928T2 (de) |
| DK (1) | DK1206436T3 (de) |
| ES (1) | ES2228587T3 (de) |
| MX (1) | MXPA02000828A (de) |
| PT (1) | PT1206436E (de) |
| TR (1) | TR200200263T2 (de) |
| WO (1) | WO2001009076A2 (de) |
| ZA (1) | ZA200200516B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2178B1 (en) * | 1999-10-19 | 2003-04-23 | اف . هوفمان لاروش ايه جي | Treatment of invasive diseases, using selected anti-PAR materials |
| US20060189893A1 (en) * | 2005-01-06 | 2006-08-24 | Diamics, Inc. | Systems and methods for detecting abnormal cells |
| US20060161076A1 (en) * | 2005-01-06 | 2006-07-20 | Diamics, Inc. | Systems and methods for collection of cell clusters |
| US7914437B2 (en) * | 2005-02-04 | 2011-03-29 | Ams Research Corporation | Transobturator methods for installing sling to treat incontinence, and related devices |
| US8415390B2 (en) | 2008-05-30 | 2013-04-09 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
| US9119777B2 (en) | 2008-05-30 | 2015-09-01 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
| EP3067054B1 (de) | 2007-09-10 | 2020-12-30 | Boston Biomedical, Inc. | Neue zusammensetzungen und verfahren für die bekämpfung von krebs |
| AU2011227023B2 (en) | 2010-03-19 | 2015-05-28 | Boston Biomedical, Inc. | Novel methods for targeting cancer stem cells |
| US8772273B2 (en) | 2011-10-04 | 2014-07-08 | Quretino Therapeutics, Inc. | Formulations and uses of retinoic acid receptor selective agonists |
| CA2856703A1 (en) * | 2011-10-19 | 2013-04-25 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
| MX2015014181A (es) | 2013-04-09 | 2016-05-24 | Boston Biomedical Inc | 2-acetilnafto [2,3-b]furano -4,9-diona para uso en el tratamiento del cáncer. |
| SI3102576T1 (sl) | 2014-02-03 | 2019-08-30 | Vitae Pharmaceuticals, Llc | Inhibitorji dihidropirolopiridina ROR-gama |
| BR112017007460A2 (pt) | 2014-10-14 | 2017-12-19 | Vitae Pharmaceuticals Inc | inibidores de di-hidropirrolopiridina de ror-gama |
| US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| ES2856931T3 (es) | 2015-08-05 | 2021-09-28 | Vitae Pharmaceuticals Llc | Moduladores de ROR-gamma |
| WO2017087608A1 (en) | 2015-11-20 | 2017-05-26 | Vitae Pharmaceuticals, Inc. | Modulators of ror-gamma |
| TWI757266B (zh) | 2016-01-29 | 2022-03-11 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| JP7106563B2 (ja) | 2016-11-29 | 2022-07-26 | スミトモ ファーマ オンコロジー， インコーポレイテッド | ナフトフラン誘導体、その調製、および使用方法 |
| US10646464B2 (en) | 2017-05-17 | 2020-05-12 | Boston Biomedical, Inc. | Methods for treating cancer |
| WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF ROR GAMMA |
| KR20200053481A (ko) | 2017-07-24 | 2020-05-18 | 비타이 파마슈티컬즈, 엘엘씨 | RORγ의 억제제 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU87821A1 (fr) * | 1990-10-12 | 1992-05-25 | Cird Galderma | Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique |
| US5958954A (en) * | 1995-09-01 | 1999-09-28 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
-
2000
- 2000-07-25 PT PT00951439T patent/PT1206436E/pt unknown
- 2000-07-25 TR TR2002/00263T patent/TR200200263T2/xx unknown
- 2000-07-25 JP JP2001514280A patent/JP3961827B2/ja not_active Expired - Fee Related
- 2000-07-25 CA CA002386793A patent/CA2386793C/en not_active Expired - Fee Related
- 2000-07-25 KR KR10-2002-7001433A patent/KR100466730B1/ko not_active Expired - Fee Related
- 2000-07-25 WO PCT/EP2000/007091 patent/WO2001009076A2/en not_active Ceased
- 2000-07-25 BR BR0012951-8A patent/BR0012951A/pt not_active Application Discontinuation
- 2000-07-25 AT AT00951439T patent/ATE279386T1/de not_active IP Right Cessation
- 2000-07-25 ES ES00951439T patent/ES2228587T3/es not_active Expired - Lifetime
- 2000-07-25 AU AU64373/00A patent/AU772551B2/en not_active Ceased
- 2000-07-25 DE DE60014928T patent/DE60014928T2/de not_active Expired - Fee Related
- 2000-07-25 EP EP00951439A patent/EP1206436B1/de not_active Expired - Lifetime
- 2000-07-25 CN CNB008112568A patent/CN1166618C/zh not_active Expired - Fee Related
- 2000-07-25 MX MXPA02000828A patent/MXPA02000828A/es active IP Right Grant
- 2000-07-25 DK DK00951439T patent/DK1206436T3/da active
- 2000-07-26 US US09/625,806 patent/US6528677B1/en not_active Expired - Fee Related
- 2000-07-31 AR ARP000103950A patent/AR024998A1/es unknown
-
2002
- 2002-01-21 ZA ZA200200516A patent/ZA200200516B/en unknown
- 2002-12-19 US US10/323,306 patent/US6828337B2/en not_active Expired - Fee Related
-
2004
- 2004-11-02 US US10/979,355 patent/US20050113447A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TR200200263T2 (tr) | 2004-12-21 |
| JP3961827B2 (ja) | 2007-08-22 |
| KR20020030089A (ko) | 2002-04-22 |
| KR100466730B1 (ko) | 2005-01-24 |
| AR024998A1 (es) | 2002-11-06 |
| ES2228587T3 (es) | 2005-04-16 |
| CN1368946A (zh) | 2002-09-11 |
| WO2001009076A2 (en) | 2001-02-08 |
| AU772551B2 (en) | 2004-04-29 |
| DE60014928D1 (de) | 2004-11-18 |
| PT1206436E (pt) | 2004-12-31 |
| EP1206436A2 (de) | 2002-05-22 |
| EP1206436B1 (de) | 2004-10-13 |
| US6828337B2 (en) | 2004-12-07 |
| MXPA02000828A (es) | 2002-07-30 |
| ZA200200516B (en) | 2003-06-25 |
| JP2003526626A (ja) | 2003-09-09 |
| WO2001009076A3 (en) | 2001-07-19 |
| DE60014928T2 (de) | 2006-03-09 |
| CA2386793C (en) | 2006-03-28 |
| DK1206436T3 (da) | 2005-02-14 |
| AU6437300A (en) | 2001-02-19 |
| US20050113447A1 (en) | 2005-05-26 |
| CN1166618C (zh) | 2004-09-15 |
| US6528677B1 (en) | 2003-03-04 |
| US20030176726A1 (en) | 2003-09-18 |
| BR0012951A (pt) | 2002-04-30 |
| CA2386793A1 (en) | 2001-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE413375T1 (de) | Retinoide zur behandlung von emphysem | |
| ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| DE69936890D1 (de) | Vorrichtung zur Behandlung von Ischämie | |
| ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
| DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
| DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| ATE247987T1 (de) | Behandlung zur beseitigung von gerüchen | |
| DE69821667D1 (de) | Kardioverter zur Behandlung von Vorhofflattern | |
| DE60234760D1 (de) | Phenylindole zur behandlung von hiv | |
| ATE269303T1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| DE60012138D1 (de) | Gerät zur behandlung von fibrillation | |
| ATE254913T1 (de) | Diacerein zur behandlung von psoriasis | |
| ATE344661T1 (de) | Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE60035326D1 (de) | Verfahren zur Behandlung von Abwasser | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| EP1117431A4 (de) | Behandlung von acidose | |
| DE60224650D1 (de) | Vorrichtung zur behandlung von vorhof-fibrillation | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1206436 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |